Mammalian target of rapamycin inhibitors (mTORis) are immunosuppression agents that are commonly used in solid organ transplantation. Available mTORis include sirolimus and everolimus. Interstitial lung disease (ILD) is an uncommon side effect of mTORis in liver transplantation. A high index of suspicion is needed, and timely intervention can reverse the disease. We present a case of sirolimus-induced ILD that improved after discontinuation of sirolimus.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728530 | PMC |
| http://dx.doi.org/10.1016/j.jceh.2018.09.005 | DOI Listing |
Publication Analysis
Top Keywords
case sirolimus-induced
8
interstitial lung
8
lung disease
8
liver transplantation
8
sirolimus-induced interstitial
4
disease liver
4
transplantation mammalian
4
mammalian target
4
target rapamycin
4
rapamycin inhibitors
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!